Patents for C12P 17 - Preparation of heterocyclic carbon compounds with only o, n, s, se, or te as ring hetero atoms (13,366)
07/2004
07/29/2004WO2004063383A1 Ionic liquids
07/29/2004WO2004062558A2 Process for enzymatic synthesis of βετα-lactam antibiotics
07/29/2004US20040147766 Intermediates for producing spinosyns
07/29/2004US20040146997 using bacterium grown in the presence of lysine or deregulated for lysine biosynthesis; genetic engineering
07/29/2004US20040146992 Method for production of polyketides
07/29/2004CA2512744A1 Ionic liquids
07/28/2004EP1440158A1 Method for the production of (r)- and (s)-8-chloro-6-hydroxy-octanic acid alkyl esters by enzymatic reduction
07/28/2004EP1440150A2 Pyranosone dehydratase from phanerochaete chrysosporium
07/28/2004EP1440078A1 Antimicrobial use of anhydrofructose derivatives
07/28/2004CN1515674A Biological pure culture for Nocardia
07/28/2004CN1515673A Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative
07/28/2004CN1159448C Process for preparation HMG-CoA reducrtase inhibitors
07/22/2004WO2004061116A2 Compositions and methods for hydroxilating epothilones
07/22/2004WO2004040955A3 Microbiological method for producing ascorbic acid
07/22/2004WO2003089452B1 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase
07/22/2004US20040142990 Concentrating epothilone in culture; complexing; antiproliferative agents
07/22/2004US20040141954 composition comprising a daidzein-containing substance and a strain of microorganism capable of metabolizing daidzein to equol as essential ingredients
07/22/2004CA2510079A1 Compositions and methods for hydroxilating epothilones
07/21/2004EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
07/21/2004CN1514880A Method and compositions for making emamectin
07/21/2004CN1513982A Red sea bacillus and its separating and culturing method and fermentation technology and use
07/20/2004US6764842 Enantioselective bioreduction for the preparation of integrin receptor antagonist intermediates
07/15/2004WO2004058976A2 Borrelidin-producing polyketide synthase and its use
07/15/2004WO2003045312A3 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin
07/15/2004US20040139499 encoded by a nucleic acid isolated from a Euphorbia lagascae developing seed cDNA library; chimeras; genetic engineering
07/15/2004US20040139496 may be derived from a single species or may be hybrid in nature; for biosynthesis; open reading frames; genetic engineering
07/15/2004US20040138446 Biotin derivative with ether, amide or amine group for detection of drug interactions.
07/15/2004US20040138280 Prepared by fermentation by microorganism Stachybotris; anticoagulants, anticarcinogenic, antitumor, antidiabetic, and antihypoxic agents; cardiovascular disorders, angina pectoris, septic shock, arteriosclerosis
07/15/2004US20040138218 Antitumor agents; antidiabetic agents; anticarcinogenic agents
07/15/2004US20040138196 Salinosporamides and methods for use thereof
07/15/2004US20040137584 Biotin biosynthetic genes
07/15/2004US20040137583 high optical density [OD] from the group selected from an algae whose life cycle has sexual/asexual reproduction and vegetative propagation: Galaxaura oblongata, Halymenia ceylanica, Helminthocladia australis, and Porphyra dentata
07/15/2004CA2506669A1 Borrelidin-producing polyketide synthase and its uses
07/14/2004EP0901468B1 Preparation of lactams from aliphatic alpha,omega-dinitriles
07/14/2004CN1513056A Production of bioarailable folic acid
07/14/2004CN1511943A Engineering strain and its preparing method, and method for preparing taxol thereof
07/14/2004CN1511942A Red rice mould mutant strain and its use in preparing fermented product with blood pressure reducing activity
07/14/2004CN1157391C Method and intermediate for preparing is-a-oxazole formylamine and its analogue
07/08/2004WO2004057011A1 Antibiotics caprazamycins d, g, d1 and g1 and process for producing the same
07/08/2004WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
07/08/2004WO2004044180A8 Method for producing polyketides
07/08/2004US20040132784 1-optionally protected hydroxy-2-aminoalkylaryl compounds, especially in which the amino and hydroxy groups are joined by a carbonyl to form an oxazolidinone ring; immunosuppressants
07/08/2004US20040132154 Chlorohydrin and hydroxycarboxylic ester asymmetric hydrolase gene
07/08/2004US20040132146 Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B
07/08/2004CA2510069A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
07/07/2004EP1434870A1 Enzymatic process for the preparation of substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acid
07/07/2004CN1511192A Production of polyketides
07/07/2004CN1510132A Gamma-tocopherol tranferase, gene and use thereof
07/07/2004CN1156581C Liposome encapsulated baccatin III derivative and its usage
07/07/2004CN1156467C 3-deoxy-3-carbonyl-erycin lactone B and its engineering strain and application
07/06/2004US6759536 Genetic engineering; polyketides
07/06/2004CA2298427C Microbial conversion of 2-methylquinoxaline
07/01/2004WO2004055021A1 Novel spirobenzofuranlactams and the derivatives thereof, methods for the production thereof, and use thereof
07/01/2004US20040128709 Composite utilization of a group of genes in biosynthetic pathway of caffeine
07/01/2004CA2508229A1 Novel spirobenzofuranlactams and the derivatives thereof, methods for the production thereof, and use thereof
06/2004
06/30/2004EP1433857A1 Process for producing monomer
06/30/2004EP0945436B1 Cytotrienins, process for preparing the same, and antitumor agent
06/30/2004CN1509335A Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
06/30/2004CN1509334A Transformant producing PF1022 substance derivatives, process for producing same and novel/biosynthesis gene
06/30/2004CN1508255A Method for producing gluconic acid lactone
06/30/2004CN1155717C Immobile polyphenol oxidase catalyzed high-purity tea polyphenol process of producing high-purity theaflavin
06/24/2004WO2004053125A1 Mutant d-aminotransferase and process for producing optically active glutamic acid derivative using the same
06/24/2004WO2004053110A1 Microorganism producing 5'-xanthylic acid
06/24/2004WO2004053065A2 Disorazole polyketide synthase encoding polynucleotides
06/24/2004WO2004052829A1 Process for producing optically active 3-hydroxypropionic ester derivative
06/24/2004WO2003105724A3 Novel maxi-k channel blockers, methods of use and process for making the same
06/24/2004WO2003064617A9 Pestalotiopsis microsporia isolates and compounds derived therefrom
06/24/2004US20040121347 Isolation and expression of a gene for a nitrilase from Acidovorax facilis 72W
06/24/2004DE10258650A1 New spirobenzofuran-lactam derivatives, useful for treating e.g. thromboembolic diseases by inhibition of platelet activation inhibitor-1, also new Stachybotris strain that produces them
06/23/2004EP1431287A1 Optically pure paroxetine precursos
06/23/2004EP1430118A2 A gene encoding cyclododecanone monooxygenase
06/23/2004EP1274698B1 Percyquinnin, a process for its production and its use as a pharmaceutical
06/23/2004CN1507443A Method for producing 2-azetidinone derivative
06/23/2004CN1154722C Biological synthetic gene II of boitin
06/17/2004WO2004050890A1 Process for producing macrolide compound
06/17/2004WO2004050889A2 Enzymatic production of acyl flavonoid derivatives
06/17/2004WO2004050862A1 Microorganism for producing riboflavin and method for producing riboflavin using the same
06/17/2004WO2004050795A2 Antioxidant-functionalized polymers
06/17/2004WO2004050684A2 Methods for improving secondary metabolite production in fungi
06/17/2004US20040116499 treatment of inflammatory or proliferative diseases of the skin and other organ systems; from yeast of the genus Malassezia; for example, 2,3-dihydro-4,5-bis(indol-3-yl)furan-2,3-dione; against multiresistent staphylococci
06/17/2004US20040116334 Useful as anti-bacterial agents
06/17/2004US20040115781 Extraction from solution; purification; salt formin g using aqueous solution of sodium hydroxide; scavenging using water insoluble ion exchange resin
06/17/2004US20040115762 Comprises nucleotide sequences coding enzymatic polypeptide associated biosynthesis of nystatin and treatment of bacterial, fungal and parasitic infections; immunosuppressant; antitumor agents
06/17/2004US20040115245 Autoinducer compounds and their uses
06/17/2004CA2508544A1 Methods for improving secondary metabolite production in fungi
06/17/2004CA2507641A1 Method of producing macrolide compound
06/16/2004EP1428826A2 Crystal forms of cytostatics
06/16/2004CN1504565A Microorganism for producing riboflavin and method for producing riboflavin using the same
06/15/2004US6750256 Use of aromatic aldehydes as insecticides
06/15/2004US6750047 Fermentation and purification of migrastatin and analog
06/15/2004US6750040 By incubating appropriate substrate set; for making a library of polyketides
06/10/2004WO2004048590A1 Stereoselective process for the production of dioxolane nucleoside analogues
06/10/2004WO2004035010A8 Methods and organisms for production of b6 vitamers
06/10/2004US20040110796 preparation of lower alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid and the use of the compound in preparing the corresponding acid
06/10/2004US20040110257 Production of farnesol and geranylgeraniol
06/10/2004US20040110248 Bacillus subtilis which is resistant to threonine analogue; high concentration in high yield
06/09/2004EP1426446A1 Microorganism for producing riboflavin and method for producing riboflavin using the same
06/09/2004EP1426445A1 Preparation of flavonoid derivatives
06/09/2004EP1425407A2 Enzymatic resolution of t-butyl taxane derivatives
06/09/2004CN1152881C New indolocarbazole alkaloids from marine actinomycete, its composition and use
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 134